Editorial: Emerging Biomarkers for NSCLC: Recent Advances in Diagnosis and Therapy

by Umberto Malapelle, Etienne Giroux Leprieur, Etienne Giroux Leprieur, Paul Takam Kamga, Marius Tresor Chiasseu, Marius Tresor Chiasseu, Christian Rolfo
Published 2021-05-01

Hedgehog Signaling in Lung Cancer: From Oncogenesis to Cancer Treatment Resistance

by Etienne Giroux-Leprieur, Adrien Costantini, Vivianne W. Ding, Biao He
Published 2018-09-01

Fatal Haemoptysis Associated with Dramatic Response to Crizotinib in an ALK-Rearranged Lung Adenocarcinoma

by Elodie Mussat, Violaine Giraud, Catherine Julie, Thierry Chinet, Etienne Giroux Leprieur
Published 2016-03-01

Successful pulmonary arterial embolization followed by curative surgery for a lepidic predominant lung adenocarcinoma with severe hypoxemia

by Louise Sebane, Mostafa El-Hajjam, Philippe Puyo, Elisabeth Longchampt, Etienne Giroux Leprieur
Published 2018-04-01

Plasma Biomarkers and Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: New Tools for Better Patient Selection?

by Adrien Costantini, Paul Takam Kamga, Coraline Dumenil, Thierry Chinet, Jean-François Emile, Etienne Giroux Leprieur
Published 2019-08-01

Clinical factors associated with early progression and grade 3-4 toxicity in patients with advanced non-small-cell lung cancers treated with nivolumab.

by Coraline Dumenil, Marie-Ange Massiani, Jennifer Dumoulin, Violaine Giraud, Sylvie Labrune, Thierry Chinet, Etienne Giroux Leprieur
Published 2018-01-01

Sequential ctDNA whole-exome sequencing in advanced lung adenocarcinoma with initial durable tumor response on immune checkpoint inhibitor and late progression

by Coraline Dumenil, Jennifer Dumoulin, Violaine Giraud, Sylvie Labrune, Catherine Julie, Etienne Giroux Leprieur, Paul Takam Kamga, Adrien Costantini, Alexandre Corjon, Simon Garinet
Published 2020-06-01

Circulating tumor DNA evaluated by Next-Generation Sequencing is predictive of tumor response and prolonged clinical benefit with nivolumab in advanced non-small cell lung cancer

by Etienne Giroux Leprieur, Guillaume Herbretau, Coraline Dumenil, Catherine Julie, Violaine Giraud, Sylvie Labrune, Jennifer Dumoulin, Julie Tisserand, Jean-François Emile, Hélène Blons, Thierry Chinet
Published 2018-05-01

Predictive role of plasmatic biomarkers in advanced non-small cell lung cancer treated by nivolumab

by Adrien Costantini, Catherine Julie, Coraline Dumenil, Zofia Hélias-Rodzewicz, Julie Tisserand, Jennifer Dumoulin, Violaine Giraud, Sylvie Labrune, Thierry Chinet, Jean-François Emile, Etienne Giroux Leprieur
Published 2018-08-01

Baseline Hedgehog Pathway Activation and Increase of Plasma Wnt1 Protein Are Associated with Resistance to Immune Checkpoint Inhibitors in Advanced Non-Small-Cell Lung Cancer

by Camille Mehlman, Paul Takam Kamga, Adrien Costantini, Catherine Julié, Coraline Dumenil, Jennifer Dumoulin, Julia Ouaknine, Violaine Giraud, Thierry Chinet, Jean-François Emile, Etienne Giroux Leprieur
Published 2021-03-01

Plasma Biomarkers Screening by Multiplex ELISA Assay in Patients with Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors

by Adrien Costantini, Paul Takam Kamga, Catherine Julie, Alexandre Corjon, Coraline Dumenil, Jennifer Dumoulin, Julia Ouaknine, Violaine Giraud, Thierry Chinet, Martin Rottman, Jean-François Emile, Etienne Giroux Leprieur
Published 2021-12-01

Positive plasma cotinine during platinum-based chemotherapy is associated with poor response rate in advanced non-small cell lung cancer patients.

by Philippine Dacosta-Noble, Adrien Costantini, Coraline Dumenil, Jennifer Dumoulin, Pierre Helly de Tauriers, Violaine Giraud, Sylvie Labrune, Jean-François Emile, Jean-Claude Alvarez, Thierry Chinet, Etienne Giroux Leprieur
Published 2019-01-01

Role of antibiotic use, plasma citrulline and blood microbiome in advanced non-small cell lung cancer patients treated with nivolumab

by Julia Ouaknine Krief, Pierre Helly de Tauriers, Coraline Dumenil, Nathalie Neveux, Jennifer Dumoulin, Violaine Giraud, Sylvie Labrune, Julie Tisserand, Catherine Julie, Jean-François Emile, Thierry Chinet, Etienne Giroux Leprieur
Published 2019-07-01

Association of the Metabolic Score Using Baseline FDG-PET/CT and dNLR with Immunotherapy Outcomes in Advanced NSCLC Patients Treated with First-Line Pembrolizumab

by Romain-David Seban, Jean-Baptiste Assié, Etienne Giroux-Leprieur, Marie-Ange Massiani, Michael Soussan, Gérald Bonardel, Christos Chouaid, Margot Playe, Lucas Goldfarb, Boris Duchemann, Laura Mezquita, Nicolas Girard, Laurence Champion
Published 2020-08-01

Gli as a novel therapeutic target in malignant pleural mesothelioma.

by Hui Li, Natalie Lui, Tiffany Cheng, Hsin-Hui K Tseng, Dongsheng Yue, Etienne Giroux-Leprieur, Hanh T Do, Qing Sheng, Joy Q Jin, Thomas W Luh, David M Jablons, Biao He
Published 2013-01-01

Efficacy of next treatment received after nivolumab progression in patients with advanced nonsmall cell lung cancer

by Adrien Costantini, Jennifer Corny, Vincent Fallet, Sophie Renet, Sylvie Friard, Christos Chouaid, Boris Duchemann, Etienne Giroux-Leprieur, Laurent Taillade, Ludovic Doucet, Marina Nguenang, Stéphane Jouveshomme, Marie Wislez, Jean Tredaniel, Jacques Cadranel
Published 2018-04-01

Predictive Value of Soluble PD-1, PD-L1, VEGFA, CD40 Ligand and CD44 for Nivolumab Therapy in Advanced Non-Small Cell Lung Cancer: A Case-Control Study

by Manuela Tiako Meyo, Anne Jouinot, Etienne Giroux-Leprieur, Elizabeth Fabre, Marie Wislez, Marco Alifano, Karen Leroy, Pascaline Boudou-Rouquette, Camille Tlemsani, Nihel Khoudour, Jennifer Arrondeau, Audrey Thomas-Schoemann, Hélène Blons, Audrey Mansuet-Lupo, Diane Damotte, Michel Vidal, François Goldwasser, Jérôme Alexandre, Benoit Blanchet
Published 2020-02-01

EMX2 Is a Predictive Marker for Adjuvant Chemotherapy in Lung Squamous Cell Carcinomas.

by Dongsheng Yue, Hui Li, Juanjuan Che, Yi Zhang, Bhairavi Tolani, Minli Mo, Hua Zhang, Qingfeng Zheng, Yue Yang, Runfen Cheng, Joy Q Jin, Thomas W Luh, Cathryn Yang, Hsin-Hui K Tseng, Etienne Giroux-Leprieur, Gavitt A Woodard, Xishan Hao, Changli Wang, David M Jablons, Biao He
Published 2015-01-01